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Background/Objectives: Brain-derived neurotrophic factor (BDNF) and its receptor 
(tropomyosin-related kinase B: TrkB, also known as Ntrk2) play a key role in central 
regulation of the energy balance. BDNF and TrkB are also expressed in peripheral tissues, 
including adipose tissue, but their peripheral role has been unclear. Here I report on the 
functional significance of the adipose tissue BDNF/TrkB axis in metabolic homeostasis. 
Methods: To examine the role of the BDNF/TrkB axes in central and peripheral tissues, I 
generated adipocyte-specific or neuron-specific BDNF/TrkB conditional knockout (CKO) 
mice. Then I compared the feeding behavior and metabolic profile between CKO mice and 
their littermates. 
Results: Expression of Bdnf/Ntrk2 in adipose tissue showed dramatic changes in obese 
mice. The first line of adipocyte-specific BDNF/TrkB CKO mice created using Fabp4-Cre 
mice displayed hyperphagia, obesity, and aggressiveness, probably due to ectopic 
Fabp4-Cre mediated gene recombination in brain. In the second line of adipocyte-specific 
BDNF/TrkB CKO mice, adipose tissue expression of Ntrk2, but not Bdnf, was reduced by 
Adipoq-Cre mediated gene recombination, indicating that adipocytes only expressed TrkB. 
When adipocyte-specific TrkB CKO mice were fed a normal diet, no phenotypic changes 
were detected, while female CKO mice on a high-calorie diet showed a decrease of food 
intake and resistance to obesity. 
Conclusions: The adipose tissue BDNF/TrkB axis has a substantial influence on feeding 
behavior and obesity in female mice. 
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Introduction 
Obesity has become a serious health problem because of its growing prevalence, numerous 
associated diseases, and lack of effective treatment
1
. The main cause of obesity is an 
imbalance between calorie intake and energy expenditure, resulting in accumulation of 
body fat. Although regulation of food intake is potentially an effective therapeutic strategy, 
difficulty in achieving control usually leads to failure. Physiological regulation of the 
energy balance involves input from both the brain and peripheral tissues. For example, 
adipose tissue releases molecules that reflect the nutritional state and fat accumulation, such 
as leptin
2
, adiponectin
3
, and certain metabolites like fatty acids
4
. These molecules transmit 
signals to the energy homeostasis center in the hypothalamus, which in turn regulates food 
intake and energy expenditure in several peripheral tissues. Identifying the complicated 
interaction between the brain and peripheral tissues involved in regulating food intake may 
provide new effective therapeutic options for obesity. 
 Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophic factor 
family that shows high-affinity binding to its receptor (tropomyosin-related kinase B: TrkB, 
also known as Ntrk2) and plays a key role in regulating neuronal survival, neuronal 
differentiation, and synaptic plasticity
5-8
. BDNF and the TrkB receptor are expressed in 
various brain regions, including energy homeostasis centers within the hypothalamus and 
the hindbrain in adult animals
9-13
. Consistent with this pattern of expression, BDNF has an 
essential role in regulating body weight and energy homeostasis. Chronic infusion of 
BDNF into the cerebral ventricles has been shown to reduce food intake and body weight
14, 
15
, while heterozygous Bdnf-deficient mice display increased locomotor activity, 
aggressiveness, hyperphagia, and obesity
16, 17
. In addition, mice expressing TrkB at 
approximately one quarter of the normal level exhibit hyperphagia and obesity
9
. Similarly, 
mice lacking neuronal Bdnf develop obesity and anxiety
18
. In humans, genome-wide 
 4 
association studies
19-22
 and rare cases of genetic variants of BDNF
23
 and NTRK2 (ref. 24) 
have shown an association between the BDNF/TrkB axis and obesity in both adults and 
children. 
 A number of studies have demonstrated that BDNF and TrkB are also expressed in 
non-neural tissues and have an influence on eating behavior and metabolic homeostasis. It 
was reported that skeletal muscle BDNF is induced by exercise and enhances fat oxidation 
by muscle
25
. In addition, mice with hepatocyte-specific Bdnf deficiency show normal food 
intake and body weight, but are protected against diet-induced metabolic abnormalities
26
. 
Furthermore, it has been demonstrated that BDNF-expressing hematopoietic cells regulate 
feeding behavior and energy balance by migrating from bone marrow to the paraventricular 
nucleus of the hypothalamus 
27
. Moreover, it was reported that BDNF is expressed in 
adipose tissue 
28, 29
. It is well known that humoral factors released by adipose tissue, 
collectively termed adipokines, participate in the regulation of energy expenditure and 
glucose/lipid metabolism through various systemic actions
2, 30, 31
. Taken together, these 
reports suggest the possibility that the BDNF/TrkB axis in adipose tissue may play a role in 
the regulation of systemic metabolism, but its actual role has been unclear. To test this 
hypothesis, I investigated adipose tissue expression of BDNF and TrkB in a dietary obesity 
model and generated various conditional knockout (CKO) mouse models by using the 
Cre-loxP system. Here I report that the adipose tissue BDNF/TrkB axis has a critical role in 
regulating metabolic homeostasis. 
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Methods 
Animal Models 
All animal care and experimental procedures were approved by the Chiba University 
review board. Mice were housed in individual cages in a temperature-controlled facility 
with a 12-h day/night cycle and free access to water. The mice were fed a normal chow diet 
(CLEA Rodent diet CE-2; CLEA Japan, Inc., Tokyo, Japan) or a high-fat/high-sucrose diet 
(F2HFHSD, Oriental Yeast, Suita, Japan) from 6 weeks of age. C57BL/6 mice were 
purchased from Japan SLC, Inc. (Shizuoka, Japan). Floxed Bdnf mice, Syn1-Cre mice, and 
Fabp4-Cre mice (with a C57BL/6 background) were purchased from the Jackson 
Laboratory (Bar Harbor, ME). Generation and genotyping of floxed Ntrk2 mice (a gift from 
Luis F. Parada, University of Texas Southwestern Medical Center, Dallas, TX) and 
Adipoq-Cre mice (a gift from Evan D. Rosen, Beth Israel Deaconess Medical Center, 
Boston, MA) have been described previously
32, 33
. 
 The genotypes of the mice and Cre-mediated recombination were assessed by PCR 
using genomic DNA harvested from tail tips and various other tissues of mutant mice. To 
examine tissue-specific deletion of BDNF or TrkB in CKO mice, I analyzed male mice 
homozygous for the floxed allele with one copy of the Cre recombinase transgene (CKO), 
littermate mice homozygous for the floxed allele without the Cre recombinase transgene 
(littermate controls), and wild-type C57BL/6 mice using the following primers: Cre 
recombinase, 5’-GTTCGCAAGAACCTGATGGACA-3’ and 
5’-CTAGAGCCTGTTTTGCACGTTC-3’; wild-type or floxed Bdnf allele, 
5'-TGTGATTGTGTTTCTGGTGAC-3’, 5’-GATACATCATGGGCAGTGGA-3’; wild-type 
or floxed Ntrk2 allele, 5’-ATGTACTCGTTCTACAAATCCTGC-3’, 
5’-TCCAGACACATACACGTGCGTGC-3’, and 
5’-CAAGAAGTCAGAGACCAGAGAGA-3’.  
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RNA analysis 
Total RNA was extracted from adipose tissue using an RNeasy Plus Universal kit (Qiagen) 
and was extracted from other tissues with RNA-Bee (Molecular Research Center). Then 
reverse transcription was performed using a QuantiTect reverse transcription kit (Qiagen), 
and real-time PCR was done with a LightCycler (Roche), the Taqman Universal Probe 
Library, and Light Cycler Master (Roche) according to the manufacturer’s instructions. For 
normalization of gene expression, 36B4 mRNA was measured as the internal control. Data 
were analyzed by the 2-1ΔΔCT method. The following primers were employed: 36B4, 
forward GATGCCCAGGGAAGACAG, reverse ACAATGAAGCATTTTGGATAATCA; 
Bdnf, forward GCCTTTGGAGCCTCCTCTAC, reverse GCGGCATCCAGGTAATTTT; 
Ntrk2, forward CGAACCTGCAGATACCCAAT, reverse TGCAGGAAAGGGTCACAGA; 
Ntrk2-tk, forward TTCTGCCTGCTGGTGATGT, reverse 
TCCAGTGGGATCTTATGAAACA. 
 
Measurement of body weight and food intake  
Body weight was measured every two weeks. Food intake was assessed by housing mice 
individually. The animals were fed a normal diet or a high-calorie diet ad libitum, and the 
amount of residual food was weighed for a total of 7 days. In pair-feeding experiments, the 
same amount of a high-calorie diet was given to CKO mice and their littermates each day. 
 
Assessment of locomotor activity 
Locomotor activity was assessed by using an implantable intra-abdominal radiofrequency 
probe and receiver (TA10TA-F20 and RPC-1, Data Sciences International) (Barber et al., 
2004). Mice (14-16 weeks old) were placed individually into cages and baseline locomotor 
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activity was monitored. Data were sampled in the continuous mode and analyzed by 
Dataquest ART2.1.  
 
CT scanning  
The adipose tissue of mice was examined by CT (LaTheta, ALOCA) according to the 
manufacturer’s protocol. I obtained CT scans at 2 mm intervals from diaphragm to the floor 
of the pelvic cavity. 
 
Laboratory Tests 
In the glucose tolerance test, mice were fasted for 16 hours and D-glucose (2 g kg
–1
 body 
weight) was administered by intraperitoneal injection at 3:00 p.m. To perform the insulin 
tolerance test, mice were given human insulin intraperitoneally (1 U kg
–1
 body weight) at 
3:00 p.m. without fasting. Blood was collected from the tail vein at 0, 15, 30, 60, and 120 
minutes after administration of glucose or insulin. Then blood glucose concentrations were 
measured with a Glutest Mint (Sanwa Kagaku Kenkyusho, Nagoya, Japan), while plasma 
insulin levels were measured by immunoassay (Morinaga). 
 
Statistical Analysis 
Results are shown as the mean ± SEM. Differences between groups were examined by 
Student’s t-test for comparison of mean values. In all analyses, p < 0.05 was considered 
statistically significant.  
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Results 
Expression of Bdnf and Ntrk2 in peripheral tissues 
I first examined the expression of Bdnf and Ntrk2 in various tissues of mice fed a normal 
diet. Bdnf was highly expressed in the brain, whereas intermediate expression was found in 
the heart, lung, and kidney (Fig.1A). Bdnf was also expressed in adipose tissue, although its 
expression was much lower than in neural tissues. Ntrk2 (the gene coding for TrkB) was 
also expressed by adipose tissue at the highest level among the peripheral tissues that I 
examined (Fig. 1B). To investigate the role of the adipose tissue BDNF/TrkB axis in obesity, 
I examined Bdnf and Ntrk2 expression in mice with dietary obesity fed a 
high-fat/high-sucrose (HFHS) diet. I found that Bdnf expression was markedly up-regulated 
in the adipose tissue of these mice (Fig. 1C), while no significant change of Bdnf 
expression was observed in other peripheral tissues (data not shown). Unlike Bdnf, 
expression of Ntrk2 was significantly down-regulated in the adipose tissue of obese mice 
(Fig. 1D). Based on these findings and previous observations
28, 29
, I speculated that the 
adipose tissue BDNF/TrkB axis might play a role in regulating metabolic homeostasis. 
 
Mice with adipocyte-specific Bdnf or Ntrk2 deficiency exhibit obesity and hyperphagia 
To study the role of the BDNF/TrkB axis in adipose tissue, I generated mice lacking Bdnf 
or Ntrk2 in adipocytes by breeding Bdnf
flox/flox
 or Ntrk2
flox/flox
 mice with Fabp4-Cre mice 
(Fabp4-BDNF CKO mice and Fabp4-TrkB CKO mice, respectively). Both lines of mice 
exhibited age-dependent obesity (Fig. 2A, 2B), hyperphagia (Fig. 2C, 2D), and 
aggressiveness (data not shown). These phenotypic changes suggested that the CKO mice 
had abnormalities of the central nervous system. Although Fabp4 was originally identified 
as an adipocyte-specific protein, recent studies have shown that it is also expressed by other 
types of cells, including neurons
34
. Since BDNF acts on the hypothalamus to regulate 
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energy homeostasis
9, 13, 15
, I investigated the specificity of Fabp4-Cre-mediated gene 
recombination. Genomic PCR detected the excised allele of Bdnf
flox/flox
 mice in the 
hypothalamus as well as in adipose tissue of Fabp4-BDNF CKO mice (Fig. 2E). Likewise, 
the excised allele of Ntrk2
flox/flox
 mice was observed in the hypothalamus of Fabp4-TrkB 
CKO mice (Fig. 2F). Adipose tissue expression of both Bdnf and Ntrk2 was markedly 
reduced in these CKO mice (Fig. 2G, 2H). Consistent with the genomic PCR data, 
hypothalamic expression of Ntrk2 was down-regulated in Fabp4-TrkB CKO mice (Fig. 2I), 
indicating that Fabp4-Cre-mediated gene recombination in the hypothalamus could affect 
the metabolic phenotype of Fabp4-TrkB CKO mice. 
 
Neuronal Bdnf deficiency causes a similar phenotype to those of Fabp4-BDNF/TrkB 
CKO mice 
To examine whether Fabp4-Cre mediated recombination in the brain accounted for the 
obese phenotype of Fabp4-BDNF/TrkB CKO mice, I next generated mice lacking neuronal 
Bdnf by breeding Bdnf
flox/flox
 mice with Syn1-Cre mice (Syn1-BDNF CKO mice). I 
confirmed that Syn1-Cre mediated recombination was only detected in the nervous system 
by genomic PCR (Fig. 3A), in accordance with a previous report
35
. Bdnf expression was 
exclusively decreased in the brains of Syn1-BDNF CKO mice (Fig. 3B). Syn1-BDNF CKO 
mice exhibited a higher body weight compared with their littermate controls (Fig. 3C), 
which was associated with hyperphagia (Fig. 3D) and increased locomotor activity (Fig. 
3E). These results suggest that Fabp4-Cre mediated gene recombination in the brain affects 
the metabolic phenotype of Fabp4-BDNF/TrkB CKO mice.  
 
Adipocyte-specific Bdnf/Ntrk2 deletion does not cause obesity in Adipoq-Cre mice  
To eliminate the possibility of genetic recombination occurring in the brain, I generated a 
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second line of adipocyte-specific Bdnf/Ntrk2 CKO mice by breeding Bdnf
flox/flox
 or 
Ntrk2
flox/flox
 mice with Adipoq-Cre mice (Adipoq-BDNF CKO mice and Adipoq-TrkB 
CKO mice, respectively). It has been reported that Cre expression driven by the Adipoq 
promoter leads to recombination exclusively affecting adipocytes
33, 36
, and I confirmed that 
Adipoq-TrkB CKO mice exhibited adipose tissue-specific recombination (Fig. 4A) and that 
Ntrk2 expression was specifically deleted from adipose tissue (Fig. 4B). Although 
Adipoq-BDNF CKO mice revealed adipose tissue-specific recombination (Fig. 4C), Bdnf 
expression was unexpectedly not suppressed in adipose tissue (Fig. 4D), suggesting that 
adipocytes do not contribute to its expression by adipose tissue. In contrast, the pattern of 
expression in Adipoq-TrkB CKO mice supported the concept that Ntrk2 is predominantly 
expressed by adipocytes in fatty tissues. 
 I then focused on TrkB in adipose tissue to investigate the role of the BDNF/TrkB 
axis in metabolism. Since decreased adipose tissue expression of TrkB was associated with 
obesity (Fig. 1E–F), I hypothesized that BDNF might positively regulate energy 
metabolism by acting on the adipocyte TrkB. I monitored physiological parameters in male 
and female mice on a normal diet, revealing that Adipoq-TrkB CKO mice and their 
littermate controls showed no differences of body weight (Fig. 5A, 5B), fat mass (Fig. 5C, 
5D), food intake (Fig. 5E, 5F), or locomotor activity (Fig. 5G, 5H). Consistent with the 
results for Bdnf expression, Adipoq-Bdnf CKO mice did not display any phenotypic 
changes (data not shown). To assess the role of the adipose tissue BDNF/TrkB axis in 
glucose homeostasis, I performed a glucose tolerance test and an insulin tolerance test, and 
I measured plasma levels of insulin during the glucose tolerance test. Normal glucose 
metabolism was observed in both sexes (Fig. 5I–L). Taken together, these results suggest 
that adipose tissue Ntrk2 only has a minor role in regulating eating behavior and 
metabolism in mice receiving a normal diet. 
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Adipoq-TrkB CKO female mice on a high-calorie diet show decreased food intake and 
resistance to obesity 
I next examined the effect of a high-calorie diet on the metabolic phenotype of 
Adipoq-TrkB CKO mice. I found that female, but not male, Adipoq-TrkB CKO mice fed a 
high-calorie diet had a lower body weight (Fig. 6A, 6B) and less accumulation of adipose 
tissue (Fig. 6C, 6D) than their littermate controls. Adipoq-TrkB CKO female mice (but not 
male mice) showed a decrease of food intake (Fig. 6E, 6F), suggesting that TrkB deficiency 
in adipose tissue leads to weight loss due to lower calorie intake. To test this hypothesis, I 
next performed a pair-feeding experiment. This showed that providing equal food intake 
diminished the difference of body weight between female Adipoq-TrkB CKO mice and 
their littermate controls (Fig. 6G), suggesting that TrkB may have a role in regulating food 
intake. In Adipoq-TrkB CKO mice, I assessed glucose metabolism at the age of 12–14 
weeks and at 24–26 weeks. There were no differences of fat mass, glucose tolerance, 
insulin tolerance, and the plasma insulin level between Adipoq-TrkB CKO mice and their 
littermate controls at 12–14 weeks of age (Fig. 6H–6L). In contrast, Adipoq-TrkB CKO 
female mice aged 24–26 weeks exhibited improvement of glucose tolerance and had lower 
insulin levels (Fig. 6M, 6N), presumably secondary to a decrease of fat mass. Collectively, 
these results indicate that TrkB deficiency in adipose tissue leads to decreased food intake 
and weight gain in female mice on a high-calorie diet, which in turn improves glucose 
metabolism. 
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Discussion 
In the present study, I investigated the pathophysiological role of BDNF/TrkB signaling in 
peripheral tissues. I found significant changes of Bdnf and Ntrk2 expression in the adipose 
tissue of mice with dietary obesity, with Bdnf being up-regulated and Ntrk2 being 
down-regulated. The results of adipocyte-specific CKO models have indicated that Ntrk2 is 
predominantly expressed by adipocytes, while Bdnf is mainly expressed by other cells. 
Adipocyte-specific deletion of Ntrk2 in female mice, but not male mice, receiving a 
high-calorie diet led to reduced food intake and less weight gain than in littermate controls 
due to a decrease of fat mass, indicating a potential role of adipose tissue BDNF/TrkB 
signaling in regulating both appetite and fat storage. 
 Deletion of TrkB mediated by Adipoq-Cre led to changes of eating behavior 
without any alteration of neuronal Ntrk2 expression. Since it is known that food intake is 
regulated by the hypothalamic feeding center
37
, my results suggested that the adipose tissue 
BDNF/TrkB axis remotely regulates feeding behavior in obese mice. It is noteworthy that 
the hypothalamic BDNF/TrkB axis negatively regulates the appetite in contrast to positive 
regulation by the adipose tissue BDNF/TrkB axis. The impact of the adipose tissue 
BDNF/TrkB axis on feeding behavior appears to be relatively small, since deletion of the 
hypothalamic and adipose BDNF/TrkB axes by Fabp4-Cre mediated recombination led to 
an increase of body weight with hyperphagia. It has been reported that adipose tissue 
regulates feeding behavior by secretion of adipokines
2, 3
 or by releasing metabolites such as 
fatty acids
4
. Thus, regulation of metabolism by the adipose tissue BDNF/TrkB axis could 
involve such adipokines and metabolites, but the molecular mechanisms remain to be 
determined. 
 It is unclear why deletion of adipose tissue TrkB had different effects on the 
feeding behavior of male and female mice. Estrogen regulates the expression of BDNF and 
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TrkB and has functions that overlap those of BDNF in the central nervous system
38
. In 
addition, the plasma BDNF level differs between men and women
39-41
 and is positively 
correlated with the estrogen level in female subjects
42
. These data suggest that there are 
gender differences in the biological activity of the BDNF/TrkB axis. It is widely accepted 
that estrogen regulates food intake and adiposity via the estrogen receptor
43
. Because 
adipocytes express the estrogen receptor
44
, it may mediate the effects of estrogen on food 
intake and adiposity
45, 46
. My results also raise the possibility that interaction of the 
BDNF/TrkB axis and estrogen on adipocytes, as well as in the brain, may contribute to the 
regulation of appetite and fat accumulation. 
 It has been reported that BDNF is expressed by adipocytes
29
 and might influence 
energy metabolism as one of the adipokines
47
. Although I confirmed that the expression of 
Bdnf was increased in the adipose tissue of obese mice, I did not detect a significant 
decrease of Bdnf expression in the adipose tissue of Adipoq-BDNF CKO mice. There is 
evidence that Cre expression driven by the Fabp4 promoter leads to recombination in 
macrophages as well as in adipocytes
48
, and it has been reported that macrophages express 
Bdnf
49
, suggesting that it may be mainly expressed by macrophages in adipose tissue. 
Accordingly, it is possible that an increase of infiltrating macrophages accounts for 
up-regulation of Bdnf expression in the adipose tissue of obese mice. 
 In summary, I found that the expression of BDNF/TrkB in adipose tissue was 
altered by a high-calorie diet. In contrast to the known role of the BDNF/TrkB axis in the 
central nervous system, deletion of TrkB from adipocytes led to decreased food intake and 
fat accumulation in mice fed a high-calorie diet, thereby improving various metabolic 
abnormalities associated with obesity. Thus, inhibition of the peripheral BDNF/TrkB axis 
may be a potential strategy for the treatment of dietary metabolic abnormalities. 
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Figure legends 
Figure 1. Expression of Bdnf and Ntrk2 in peripheral tissues. 
(A, B) Relative expression of Bdnf (A) and Ntrk2 (B) in mouse tissues was determined by 
real-time PCR. Expression in various tissues is shown relative to that in the cerebral cortex. 
n = 5. EWAT, epididymal white adipose tissue; BAT, brown adipose tissue. 
(C, D) Expression of Bdnf (C) and Ntrk2 (D) in epididymal white adipose tissue (EWAT), 
perinephric white adipose tissue (RWAT), and inguinal white adipose tissue (IWAT) 
assessed by real-time PCR in 16-week-old mice fed normal chow (NC) or a 
high-fat/high-sucrose (HFHS) diet. n = 9–10 for EWAT, n = 4 for RWAT, and n = 4 for 
IWAT. *p < 0.05, ***p < 0.001. Data are shown as the mean ± SEM. 
 
Figure 2. Obesity and hyperphagia in mice with adipocyte-specific deficiency of Bdnf 
or Ntrk2 developed using Fabp4-Cre mice.  
(A, B) Body weight of Fabp4-BDNF CKO mice (A) and Fabp4-TrkB CKO mice (B) 
compared with their littermate controls (Control). n = 3 for A, n = 7–11 for B. *p < 0.05, 
**p < 0.01, ***p < 0.001. 
(C, D) Food intake of Fabp4-BDNF CKO mice (C) and Fabp4-TrkB CKO mice (D) 
compared with their littermate controls (Control) at 8–12 weeks of age. n = 4–6 for C, n = 
6–8 for D. *p < 0.05, ***p < 0.001. 
(E, F) PCR analysis of genomic DNA isolated from the hypothalamus, epididymal white 
adipose tissue (EWAT), and brown adipose tissue (BAT) of Fabp4-BDNF CKO mice (E) 
and Fabp4-TrkB CKO mice (F), and from EWAT of their littermate controls and wild-type 
mice. Littermate controls were homozygous for the floxed Bdnf (E) or Ntrk2 (F) allele, but 
did not carry Cre recombinase.  
(G) Real-time PCR analysis of Bdnf expression by epididymal white adipose tissue 
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(EWAT) in Fabp4-BDNF CKO mice and their littermate controls (Control). n = 3. *p < 
0.05. 
(H, I) Real-time PCR analysis of Ntrk2 expression in epididymal white adipose tissue 
(EWAT) (H) and the hypothalamus (I) of Fabp4-TrkB CKO mice and their littermate 
controls (Control). n = 3–4. *p < 0.05, ***p < 0.001. Data are shown as the mean ± SEM. 
 
Figure 3. Neuronal Bdnf deficiency leads to similar phenotypes to those of 
Fabp4-BDNF/TrkB CKO mice. 
(A) PCR analysis of genomic DNA isolated from various tissues of Syn1-BDNF CKO mice 
and from the cerebral cortex of their littermate controls and wild-type mice. Littermates 
were homozygous for the floxed Bdnf allele, but did not carry Cre recombinase.  
(B) Real-time PCR analysis of Bdnf expression in various tissues of Syn1-BDNF CKO 
mice and their littermate controls (Control). n = 5. ***p < 0.001. 
(C) Body weight of Syn1-BDNF CKO mice and their littermate controls (Control). n = 22–
25. *p < 0.05. 
(D) Food intake of Syn1-BDNF CKO mice and their littermate controls (Control) at 8–12 
weeks of age. n = 12–14. *p < 0.05. 
(E) Locomotor activity of Syn1-BDNF CKO mice and littermate controls (Control) at 14–
16 weeks of age. n = 8. *p < 0.05. Data are shown as the mean ± SEM.  
 
Figure 4. Genomic recombination and gene expression in adipocyte-specific 
Bdnf/Ntrk2 deletion models created using Adipoq-Cre mice. 
(A) PCR analysis of genomic DNA isolated from various tissues of Adipoq-TrkB CKO 
mice and from epididymal white adipose tissue (EWAT) of their littermate controls and 
wild-type mice. Littermate controls were homozygous for the floxed Ntrk2 allele, but did 
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not carry Cre recombinase. 
(B) Real-time PCR analysis of Ntrk2 expression in various tissues of Adipoq-TrkB CKO 
mice and their littermate controls (Control). n = 5. **p < 0.01, ***p < 0.001. 
(C) PCR analysis of genomic DNA isolated from various tissues of Adipoq-BDNF CKO 
mice and from epididymal white adipose tissue (EWAT) of their littermate controls and 
wild-type mice. Littermate controls were homozygous for the floxed Bdnf allele, but did not 
carry Cre recombinase.  
(D) Real-time PCR analysis of Bdnf expression in various tissues of Adipoq-BDNF CKO 
mice and their littermate controls (Control). n = 5. Data are shown as the mean ± SEM. 
 
Figure 5. Adipocyte-specific deletion of Ntrk2 does not cause obesity. 
(A, B) Body weight of Adipoq-TrkB CKO male mice (A) and female mice (B) receiving a 
normal diet compared with their littermate controls (Control). n = 11–12 for A, n = 10–11 
for B. 
(C, D) CT analysis of Adipoq-TrkB CKO male mice (C) and female mice (D) receiving a 
normal diet compared with their littermate controls (Control) at 12–14 weeks of age. The 
percent fat tissue/body weight ratio is shown for visceral fat and subcutaneous fat. n = 6 for 
C, n = 9–10 for D. 
(E, F) Food intake of Adipoq-TrkB CKO male mice (E) and female mice (F) receiving a 
normal diet compared with their littermate controls (Control) at 8–12 weeks of age. n = 9–
10 for E, n = 9–10 for F. 
(G, H) Locomotor activity of Adipoq-TrkB CKO male mice (G) and female mice (H) 
receiving a normal diet compared with their littermate controls (Control) at 14–16 weeks of 
age. n = 6 for G, n = 6 for H. 
(I) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in Adipoq-TrkB CKO male 
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mice receiving a normal diet compared with their littermate controls (Control) at 12–14 
weeks of age. n = 9–13 for GTT, n = 10–13 for ITT. 
(J) Plasma insulin level during the GTT shown in Figure 5I. n = 9–10. 
(K) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in Adipoq-TrkB CKO 
female mice receiving a normal diet compared with their littermate controls (Control) at 
12–14 weeks of age. n = 15–16 for GTT, n = 7–10 for ITT. 
(L) Plasma insulin level during the GTT shown in Figure 5K. n = 7–10. Data are shown as 
the mean ± SEM. 
 
Figure 6. Adipoq-TrkB CKO female mice on a high-calorie diet show decreased food 
intake and resistance to obesity. 
(A, B) Body weight of Adipoq-TrkB CKO male mice (A) and female mice (B) receiving a 
high-fat/high-sucrose (HFHS) diet compared with their littermate controls (Control). n = 
14−16 for A, n = 26—33 for B. *p < 0.05, **p < 0.01. 
(C, D) CT analysis of Adipoq-TrkB CKO male mice (C) and female mice (D) receiving the 
HFHS diet compared with their littermate controls (Control) at 24 weeks of age. The 
percent fat tissue/body weight ratio is shown for visceral fat and subcutaneous fat. n = 5 for 
C, n = 7 for D. *p < 0.05. 
(E, F) Food intake of Adipoq-TrkB CKO male mice (F) and female mice (G) receiving the 
HFHS diet compared with their littermate controls (Control) at 14 weeks of age. n = 10–13 
for F, n = 14–16 for G. *p < 0.05. 
(G) Pair-feeding experiments in Adipoq-TrkB CKO female mice receiving the HFHS diet 
compared with their littermate controls (Control). n = 6. 
(H) CT analysis of Adipoq-TrkB CKO female mice receiving the HFHS diet compared with 
their littermate controls (Control) at 12–14 weeks of age. The percent fat tissue/body 
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weight ratio is shown for visceral fat and subcutaneous fat. n = 7. 
(I) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in Adipoq-TrkB CKO male 
mice receiving the HFHS diet compared with their littermate controls (Control) at 12–14 
weeks of age. n = 17–18 for GTT, n = 15–18 for ITT. 
(J) Plasma insulin level during the GTT shown in Figure 6I. n = 12–15. 
(K) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in Adipoq-TrkB CKO 
male mice receiving the HFHS diet compared with their littermate controls (Control) at 12–
14 weeks of age. n = 10–13 for GTT, n = 10 for ITT. 
(L) Plasma insulin level during the GTT shown in Figure 6K. n = 14–15. 
(M) Glucose tolerance test (GTT) and insulin tolerance test (ITT) in Adipoq-TrkB CKO 
male mice receiving the HFHS diet compared with their littermate controls (Control) at 24–
26 weeks of age. (GTT: n = 14–15 for GTT, n = 12–13 for ITT. *p < 0.05. 
(N) Plasma insulin level during the GTT shown in Figure 6M. n = 10. *p < 0.05. Data are 
shown as the mean ± SEM. 
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